Trade this ETF at your broker
Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | EUR 229 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 10.54% |
Inception/ Listing Date | 20 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | HSBC Securities Services (Ireland) |
Investment Advisor | |
Custodian Bank | HSBC Bank plc |
Revision Company | - |
Fiscal Year End | 31 December |
Swiss representative | NO |
Swiss paying agent | NO |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | No ESTV Reporting | |
Austria | Non-Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Eli Lilly & Co | 8.73% |
UnitedHealth Group | 8.33% |
Novo Nordisk | 6.70% |
AbbVie | 5.99% |
AstraZeneca | 3.64% |
Merck & Co | 3.48% |
Novartis | 3.37% |
Abbott Laboratories | 3.26% |
Thermo Fisher Scientific | 3.19% |
Roche Holding | 2.89% |
United States | 66.22% |
Switzerland | 7.67% |
United Kingdom | 5.47% |
Japan | 5.08% |
Other | 15.56% |
Health Care | 92.59% |
Consumer Discretionary | 0.51% |
Other | 6.90% |
Broker | Rating | Savings plan offer | Account fee | More information |
---|---|---|---|---|
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info |
YTD | +8.60% |
1 month | +2.62% |
3 months | +1.79% |
6 months | +13.26% |
1 year | +11.59% |
3 years | - |
5 years | - |
Since inception (MAX) | +13.60% |
2023 | +2.15% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 10.54% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 1.10 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -6.52% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -11.07% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WELS | - - | - - | - |
XETRA | USD | WEL9 | WEL9 GY IWEL9 | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 11 | 0.18% p.a. | Distributing | Full replication |